Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| oligodendrocyte precursor cell | 9 studies | 35% ± 13% | |
| mast cell | 9 studies | 47% ± 17% | |
| GABAergic neuron | 6 studies | 52% ± 22% | |
| glutamatergic neuron | 5 studies | 47% ± 24% | |
| interneuron | 5 studies | 48% ± 25% | |
| neuron | 4 studies | 19% ± 3% | |
| endothelial cell | 3 studies | 28% ± 13% | |
| amacrine cell | 3 studies | 28% ± 4% | |
| glycinergic amacrine cell | 3 studies | 21% ± 3% | |
| rod bipolar cell | 3 studies | 43% ± 18% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 8 studies | 32% ± 20% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 98% | 794.80 | 2589 / 2642 | 91% | 11.67 | 642 / 705 |
| muscle | 100% | 2824.18 | 803 / 803 | 0% | 0 | 0 / 0 |
| adrenal gland | 9% | 23.48 | 23 / 258 | 65% | 11.39 | 149 / 230 |
| bladder | 48% | 96.90 | 10 / 21 | 1% | 0.04 | 7 / 504 |
| lung | 39% | 61.99 | 223 / 578 | 2% | 0.05 | 24 / 1155 |
| prostate | 25% | 38.11 | 61 / 245 | 4% | 0.08 | 21 / 502 |
| esophagus | 26% | 47.76 | 378 / 1445 | 0% | 0 | 0 / 183 |
| intestine | 21% | 32.05 | 206 / 966 | 1% | 0.02 | 3 / 527 |
| peripheral blood | 19% | 280.63 | 175 / 929 | 0% | 0 | 0 / 0 |
| adipose | 18% | 25.56 | 220 / 1204 | 0% | 0 | 0 / 0 |
| skin | 15% | 22.81 | 275 / 1809 | 3% | 0.14 | 12 / 472 |
| uterus | 9% | 12.16 | 15 / 170 | 8% | 0.35 | 37 / 459 |
| stomach | 15% | 20.21 | 53 / 359 | 2% | 0.12 | 6 / 286 |
| lymph node | 0% | 0 | 0 / 0 | 10% | 0.49 | 3 / 29 |
| pancreas | 1% | 1.33 | 3 / 328 | 6% | 0.18 | 11 / 178 |
| breast | 6% | 8.06 | 27 / 459 | 1% | 0.01 | 7 / 1118 |
| kidney | 3% | 3.52 | 3 / 89 | 2% | 0.15 | 15 / 901 |
| heart | 5% | 12.84 | 41 / 861 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 4% | 0.09 | 2 / 45 |
| eye | 0% | 0 | 0 / 0 | 3% | 0.12 | 2 / 80 |
| thymus | 0% | 0.60 | 3 / 653 | 2% | 0.03 | 11 / 605 |
| ovary | 0% | 0 | 0 / 180 | 2% | 0.09 | 9 / 430 |
| spleen | 1% | 1.84 | 3 / 241 | 0% | 0 | 0 / 0 |
| blood vessel | 1% | 3.94 | 11 / 1335 | 0% | 0 | 0 / 0 |
| liver | 0% | 0 | 0 / 226 | 0% | 0.03 | 2 / 406 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0002244 | Biological process | hematopoietic progenitor cell differentiation |
| GO_0042552 | Biological process | myelination |
| GO_0007612 | Biological process | learning |
| GO_0007611 | Biological process | learning or memory |
| GO_0006811 | Biological process | monoatomic ion transport |
| GO_0098703 | Biological process | calcium ion import across plasma membrane |
| GO_0006874 | Biological process | intracellular calcium ion homeostasis |
| GO_0060291 | Biological process | long-term synaptic potentiation |
| GO_0098815 | Biological process | modulation of excitatory postsynaptic potential |
| GO_0051560 | Biological process | mitochondrial calcium ion homeostasis |
| GO_0048709 | Biological process | oligodendrocyte differentiation |
| GO_0007154 | Biological process | cell communication |
| GO_0007613 | Biological process | memory |
| GO_0014819 | Biological process | regulation of skeletal muscle contraction |
| GO_1903779 | Biological process | regulation of cardiac conduction |
| GO_0006851 | Biological process | mitochondrial calcium ion transmembrane transport |
| GO_0050808 | Biological process | synapse organization |
| GO_0035725 | Biological process | sodium ion transmembrane transport |
| GO_0070588 | Biological process | calcium ion transmembrane transport |
| GO_0071901 | Biological process | negative regulation of protein serine/threonine kinase activity |
| GO_0071456 | Biological process | cellular response to hypoxia |
| GO_0016528 | Cellular component | sarcoplasm |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0031594 | Cellular component | neuromuscular junction |
| GO_0043197 | Cellular component | dendritic spine |
| GO_0048471 | Cellular component | perinuclear region of cytoplasm |
| GO_0005789 | Cellular component | endoplasmic reticulum membrane |
| GO_0043204 | Cellular component | perikaryon |
| GO_0042383 | Cellular component | sarcolemma |
| GO_0043679 | Cellular component | axon terminus |
| GO_0098794 | Cellular component | postsynapse |
| GO_0043025 | Cellular component | neuronal cell body |
| GO_0030425 | Cellular component | dendrite |
| GO_0045202 | Cellular component | synapse |
| GO_0070161 | Cellular component | anchoring junction |
| GO_0014069 | Cellular component | postsynaptic density |
| GO_0005741 | Cellular component | mitochondrial outer membrane |
| GO_0030424 | Cellular component | axon |
| GO_0046872 | Molecular function | metal ion binding |
| GO_0099580 | Molecular function | monoatomic ion antiporter activity involved in regulation of postsynaptic membrane potential |
| GO_0005432 | Molecular function | calcium:sodium antiporter activity |
| GO_0005516 | Molecular function | calmodulin binding |
| Gene name | SLC8A3 |
| Protein name | Solute carrier family 8 member A3 Alternative protein SLC8A3 Sodium/calcium exchanger 3 (Na(+)/Ca(2+)-exchange protein 3) (Solute carrier family 8 member 3) SLC8A3 protein |
| Synonyms | NCX3 |
| Description | FUNCTION: Mediates the electrogenic exchange of Ca(2+) against Na(+) ions across the cell membrane, and thereby contributes to the regulation of cytoplasmic Ca(2+) levels and Ca(2+)-dependent cellular processes. Contributes to cellular Ca(2+) homeostasis in excitable cells, both in muscle and in brain. In a first phase, voltage-gated channels mediate the rapid increase of cytoplasmic Ca(2+) levels due to release of Ca(2+) stores from the endoplasmic reticulum. SLC8A3 mediates the export of Ca(2+) from the cell during the next phase, so that cytoplasmic Ca(2+) levels rapidly return to baseline. Contributes to Ca(2+) transport during excitation-contraction coupling in muscle. In neurons, contributes to the rapid decrease of cytoplasmic Ca(2+) levels back to baseline after neuronal activation, and thereby contributes to modulate synaptic plasticity, learning and memory (By similarity). Required for normal oligodendrocyte differentiation and for normal myelination . Mediates Ca(2+) efflux from mitochondria and contributes to mitochondrial Ca(2+) ion homeostasis (By similarity). . |
| Accessions | ENST00000216568.11 [P57103-5] A7E240 ENST00000533541.1 ENST00000494208.5 [P57103-3] ENST00000394330.6 [P57103-4] ENST00000528359.6 [P57103-7] ENST00000705391.1 [P57103-2] P57103 A7E249 ENST00000356921.7 [P57103-2] F2Z391 L8E9C0 ENST00000381269.6 [P57103-1] ENST00000534137.5 [P57103-6] |